Patient safety is job one in any pharmacy, but especially in compounding pharmacies. So on those rare occasions when errors occur — in your pharmacy or someone else’s — you want to be able to learn from them.
In response to inquiries from state boards of pharmacy regarding the enforceability of revised USP Chapters <795>, <797>, and <800>, a recent memo aims to clarify references in the Food, Drug & Cosmetic Act.
Last week, we sent a letter to the California Board of Pharmacy requesting clarification of its position on compounding semaglutide.
The number of APC Pharmacy-Facility Members continues to grow.
APC leaders met this week with USP staff for a touch-base. One outcome of that meeting is the need to spread the word about several USP compounding resources.
In a ruling published this week, the U.S. District Court for the Middle District of Florida, Tampa Division, granted a motion to dismiss in the case of Novo Nordisk, Inc. v. Brooksville Pharmaceuticals.
I don’t have a clever theme to unite the three things I want to share this week, so I’ll just dive in...
|
Kevin Borg of Potter’s House Apothecary, Peoria, AZ, was awarded the 2023 M. George Webber Compounding Pharmacist of the Year during PCCA’s International Seminar in Houston last week. |
PCAB announced this week that updated PCAB Accreditation Standards are now available to download.
FOLLOW US
